CUA Guideline on the Evaluation and Medical Management of the Kidney Stone Patient - 2016 Update

Overview

Journal Can Urol Assoc J

Specialty Urology

Date 2017 Jan 19

PMID 28096919

Citations 24

Authors

Marie Dion

Ghada Ankawi

Ben Chew

Ryan Paterson

Nabil Sultan

Patti Hoddinott

Hassan Razvi

Affiliations

Soon will be listed here.

Citing Articles

Effect of two vitamin D repletion protocols on 24-h urine calcium in patients with recurrent calcium kidney stones and vitamin D deficiency: a randomized clinical trial.

Sardari Masihi L, Borumandnia N, Taheri M, Basiri A, Imani H, Jalali S Eur J Med Res. 2023; 28(1):246.

PMID: 37481570 PMC: 10362614. DOI: 10.1186/s40001-023-01226-z.

A functional -1562C>T polymorphism, MMP-9 serum levels and nephrolithiasis risk in a southern Chinese population.

Ding Q, Cao C, Shi Y, Fan Z, Li F, Tu W Front Med (Lausanne). 2023; 10:1175798.

PMID: 37332754 PMC: 10272514. DOI: 10.3389/fmed.2023.1175798.

Fluid intake recommendations in urolithiasis and general advice to patients without metabolic risk factors.

Kiremit M, Boyuk A, Petkova K World J Urol. 2023; 41(5):1251-1259.

PMID: 36692534 DOI: 10.1007/s00345-023-04285-3.

On the rocks: can urologists identify stone composition based on endoscopic images alone? A worldwide survey of urologists.

Randall J, Whiles B, Carrera R, Ito W, Thompson J, Duchene D World J Urol. 2023; 41(2):575-579.

PMID: 36607392 DOI: 10.1007/s00345-022-04269-9.

International Alliance of Urolithiasis (IAU) guidelines on the metabolic evaluation and medical management of urolithiasis.

Zeng G, Zhu W, Robertson W, Penniston K, Smith D, Pozdzik A Urolithiasis. 2022; 51(1):4.

PMID: 36454329 DOI: 10.1007/s00240-022-01387-2.

References

Pearle M, Roehrborn C, Pak C . Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis. J Endourol. 1999; 13(9):679-85. DOI: 10.1089/end.1999.13.679. View

Letavernier E, Traxer O, Daudon M, Tligui M, Hubert-Brierre J, Guerrot D . Determinants of osteopenia in male renal-stone-disease patients with idiopathic hypercalciuria. Clin J Am Soc Nephrol. 2011; 6(5):1149-54. PMC: 3087782. DOI: 10.2215/CJN.10191110. View

Chow G, Streem S . Medical treatment of cystinuria: results of contemporary clinical practice. J Urol. 1996; 156(5):1576-8. DOI: 10.1016/s0022-5347(01)65451-x. View

Wang S, Zhang Y, Mao Z, He X, Zhang Q, Zhang D . A meta-analysis of coffee intake and risk of urolithiasis. Urol Int. 2014; 93(2):220-8. DOI: 10.1159/000356559. View

Borghi L, Meschi T, Maggiore U, Prati B . Dietary therapy in idiopathic nephrolithiasis. Nutr Rev. 2006; 64(7 Pt 1):301-12. DOI: 10.1301/nr.2006.jul.301-312. View

Fink H, Akornor J, Garimella P, MacDonald R, Cutting A, Rutks I . Diet, fluid, or supplements for secondary prevention of nephrolithiasis: a systematic review and meta-analysis of randomized trials. Eur Urol. 2009; 56(1):72-80. PMC: 2925677. DOI: 10.1016/j.eururo.2009.03.031. View

Meschi T, Maggiore U, Fiaccadori E, Schianchi T, Bosi S, Adorni G . The effect of fruits and vegetables on urinary stone risk factors. Kidney Int. 2004; 66(6):2402-10. DOI: 10.1111/j.1523-1755.2004.66029.x. View

Sawyer M, Anderson C, Viprakasit D, Dietrich M, Herrell S, Miller N . An individualized weight-based goal urine volume model significantly improves expected calcium concentrations relative to a 2-L goal urine volume. Urolithiasis. 2013; 41(5):403-9. DOI: 10.1007/s00240-013-0573-8. View

Pearle M, Calhoun E, Curhan G . Urologic diseases in America project: urolithiasis. J Urol. 2005; 173(3):848-57. DOI: 10.1097/01.ju.0000152082.14384.d7. View

10.

Preminger G, Sakhaee K, Pak C . Alkali action on the urinary crystallization of calcium salts: contrasting responses to sodium citrate and potassium citrate. J Urol. 1988; 139(2):240-2. DOI: 10.1016/s0022-5347(17)42374-3. View

11.

Mattoo A, Goldfarb D . Cystinuria. Semin Nephrol. 2008; 28(2):181-91. DOI: 10.1016/j.semnephrol.2008.01.011. View

12.

RODMAN J, Blackburn P, Williams J, Brown A, Pospischil M, Peterson C . The effect of dietary protein on cystine excretion in patients with cystinuria. Clin Nephrol. 1984; 22(6):273-8. View

13.

Rathod A, Bonny O, Guessous I, Suter P, Conen D, Erne P . Association of urinary calcium excretion with serum calcium and vitamin D levels. Clin J Am Soc Nephrol. 2014; 10(3):452-62. PMC: 4348692. DOI: 10.2215/CJN.12511213. View

14.

Trinchieri A, Mandressi A, Luongo P, Longo G, Pisani E . The influence of diet on urinary risk factors for stones in healthy subjects and idiopathic renal calcium stone formers. Br J Urol. 1991; 67(3):230-6. DOI: 10.1111/j.1464-410x.1991.tb15124.x. View

15.

Ettinger B, Tang A, Citron J, Livermore B, Williams T . Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med. 1986; 315(22):1386-9. DOI: 10.1056/NEJM198611273152204. View

16.

Gallagher J, Smith L, Yalamanchili V . Incidence of hypercalciuria and hypercalcemia during vitamin D and calcium supplementation in older women. Menopause. 2014; 21(11):1173-80. PMC: 4209182. DOI: 10.1097/GME.0000000000000270. View

17.

Dahlberg P, VAN DEN BERG , Kurtz S, Wilson D, Smith L . Clinical features and management of cystinuria. Mayo Clin Proc. 1977; 52(9):533-42. View

18.

Breslau N, Brinkley L, Hill K, Pak C . Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism. J Clin Endocrinol Metab. 1988; 66(1):140-6. DOI: 10.1210/jcem-66-1-140. View

19.

Ettinger B, Citron J, Livermore B, Dolman L . Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. J Urol. 1988; 139(4):679-84. DOI: 10.1016/s0022-5347(17)42599-7. View

20.

Barbey F, Joly D, Rieu P, Mejean A, Daudon M, Jungers P . Medical treatment of cystinuria: critical reappraisal of long-term results. J Urol. 2001; 163(5):1419-23. DOI: 10.1016/s0022-5347(05)67633-1. View